Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 5/2010

01-10-2010 | Clinical Trial Report

Clinical Trials Report: Sumatriptan–Naproxen Combination for Symptomatic Treatment of Comorbid Dysmenorrhea and Migraine

Author: E. Anne MacGregor

Published in: Current Pain and Headache Reports | Issue 5/2010

Login to get access

Excerpt

Mannix LK, Martin VT, Cady RK, et al.: Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol 2009, 114:106–113. …
Literature
1.
Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):1–60.
2.
Stewart WF, Wood C, Reed ML, et al.: Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008, 28:1170–1178.CrossRefPubMed
3.
MacGregor EA, Brandes J, Eikermann A, Giammarco R: Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey: Phase III. Curr Med Res Opin 2004, 20:1143–1150. (Published erratum appears in Curr Med Res Opin 2004, 20:1143–1150.)
4.
MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351–353.PubMed
5.
Marjoribanks J, Proctor M, Farquhar C, Derks RS: Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010, (1):CD001751.
6.
Suthisisang CC, Poolsup N, Suksomboon N, et al.: Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 2010, 50:808–818CrossRefPubMed
7.
McCrory DC, Gray RN: Oral sumatriptan for acute migraine. Cochrane Database Syst Rev 2003, (3):CD002915.
8.
Brandes JL, Kudrow D, Stark SR, et al.: Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007, 297:1443–1454.CrossRefPubMed
9.
Allais G, Bussone G, De Lorenzo C, et al.: Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci 2007, 28(Suppl 2):S225–S228.CrossRefPubMed
10.
Pringsheim T, Davenport WJ, Dodick D: Acute treatment and prevention of menstrually related migraine headache: Evidence-based review. Neurology 2008, 70:1555–1563.CrossRefPubMed
Metadata
Title
Clinical Trials Report: Sumatriptan–Naproxen Combination for Symptomatic Treatment of Comorbid Dysmenorrhea and Migraine
Author
E. Anne MacGregor
Publication date
01-10-2010
Publisher
Current Science Inc.
Published in
Current Pain and Headache Reports / Issue 5/2010
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-010-0134-6

Other articles of this Issue 5/2010

Current Pain and Headache Reports 5/2010 Go to the issue

ReviewPaper

Blocking the Greater Occipital Nerve: Utility in Headache Management

ReviewPaper

Effect of Treatment on Trigger Points

ReviewPaper

Prevalence of Myofascial Trigger Points in Fibromyalgia: The Overlap of Two Common Problems

ReviewPaper

Health-related Quality of Life in Patients with Myofascial Pain Syndrome

ReviewPaper

Genetics of Menstrual Migraine: The Epidemiological Evidence

ReviewPaper

New Trends in the Treatment and Management of Myofascial Pain Syndrome